A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...
Cancer is treated with multiple modalities simultaneously, such as surgery, chemotherapy, and radiation therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback